ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,275, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.).
"Immunophilin binding agents and uses thereof" was invented by Kevan M. Shokat (San Francisco), Ziyang Zhang (San Francisco), William A. Weiss (San Francisco) and QiWen Fan (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein, inter alia, are immunophilin binding compounds and methods of heating CNS diseases, including co-administering outside the CNS of a subject an anti-CNS disease drug and a compound described herein."
The patent was filed on Feb. 6, 2020, under Application No. 17/427,039.
*For further information, in...